Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.6 |
mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.024 | 0.7 |
mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.033 | 0.7 |
mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.041 | 0.7 |